European Medicines Agency accepts marketing application of Biocon, Mylan product

Mylan and Biocon, which have co-developed insulin glargine, look forward to offering another insulin treatment option for diabetic patients.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news